KMTS - CIK 0001877184
The table below shows KESTRA MEDICAL TECHNOLOGIES, LTD.'s income statement line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Revenue | $59.81M | $27.81M |
| Cost of revenue | $35.60M | $27.45M |
| Gross profit | $24.21M | $362.00K |
| R&D | $15.65M | $15.49M |
| SG&A | $114.94M | $69.94M |
| Operating income | -$106.38M | -$85.06M |
| Income tax | $135.00K | $24.00K |
| Net income | -$113.81M | -$94.12M |
| EPS (diluted) | -$5.13 | -$5.07 |
KESTRA MEDICAL TECHNOLOGIES, LTD. reported annual revenue of $59.81M for fiscal year 2025. That is up 115.1% from $27.81M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.